PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Phenotype | C0022661|end stage renal disease |
| Sentences | 3 |
| PubMedID- 26095179 | Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of hepatitis c in patients with end stage renal disease. |
| PubMedID- 25624999 | Treatment of hepatitis c in end stage renal disease patients using conventional or pegylated interferon with or without ribavirin remains a clinical challenge with low response rate, high dropout rate due to poor tolerability and many unmet needs. |
| PubMedID- 23600049 | Treatment of chronic hepatitis c in end stage renal disease: experience at a tertiary care centre. |
Page: 1